Management of patients with advanced non-small cell lung cancer: current and emerging options.

Drugs
Laura R TrianoScott N Gettinger

Abstract

Systemic therapy for advanced non-small cell lung cancer (NSCLC) has evolved over the last two decades, with modest improvements in quality of life and overall survival. A plateau has been reached with traditional chemotherapy, and efforts are now being directed at developing molecularly targeted agents. To date, three such agents have been found to improve overall survival in advanced NSCLC. Erlotinib, a small-molecule inhibitor of the epidermal growth factor receptor, was approved by the US FDA in 2004 as second- or third-line treatment for advanced NSCLC. Bevacizumab, an antibody to vascular endothelial growth factor, a key mediator of angiogenesis, received approval in 2006, after a randomized trial reported a median survival of 1 year when bevacizumab was added to first-line chemotherapy. More recently, cetuximab, an antibody to the epidermal growth factor receptor, was found to improve outcome when added to chemotherapy, and FDA approval is anticipated. Several additional agents are currently being evaluated in randomized trials, with encouraging results from early studies. These and other studies are prospectively investigating predictive clinical and molecular characteristics, with the ultimate goal of individualizing t...Continue Reading

References

Jul 17, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A J WozniakR B Livingston
Jan 7, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A B SandlerL H Einhorn
May 16, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F A ShepherdJ Berille
Jan 11, 2002·The New England Journal of Medicine·Joan H SchillerUNKNOWN Eastern Cooperative Oncology Group
May 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Masahiro FukuokaJosé Baselga
Jul 3, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Frank FossellaChandra P Belani
Sep 4, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Fred R HirschWilbur A Franklin
Mar 3, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Giuseppe GiacconeDavid H Johnson
Mar 3, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Roy S HerbstDavid H Johnson
May 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nasser HannaPaul A Bunn
Jun 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David H JohnsonFairooz Kabbinavar
Dec 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rogerio C LilenbaumMark R Green
Jul 15, 2005·The New England Journal of Medicine·Frances A ShepherdUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Jul 27, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Roy S HerbstUNKNOWN TRIBUTE Investigator Group
Nov 19, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christer SederholmSulochana R Gawande
Mar 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·DuyKhanh PhamValerie W Rusch
Mar 22, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Luis Paz-AresDavid R Gandara
May 10, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Farin KamangarWilliam F Anderson
Jun 21, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Akira InoueToshihiro Nukiwa
Sep 8, 2006·The New England Journal of Medicine·Ken A OlaussenUNKNOWN IALT Bio Investigators
Sep 13, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gerold BeplerGeorge Simon
Nov 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Fred R HirschBrian Holloway
Nov 4, 2006·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R DziadziuszkoF R Hirsch
Dec 15, 2006·The New England Journal of Medicine·Alan SandlerDavid H Johnson
Mar 21, 2007·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Noriaki SunagaMasatomo Mori
May 17, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Erminia MassarelliIgnacio I Wistuba
Jun 7, 2007·Journal of the National Cancer Institute·Andrea ArdizzoniUNKNOWN CISCA (CISplatin versus CArboplatin) Meta-analysis Group
Jul 3, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·George SimonGerold Bepler
Jul 3, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Manuel CoboRafael Rosell
Sep 1, 2007·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Peter GoldstrawUNKNOWN Participating Institutions
May 7, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lecia V SequistThomas J Lynch
May 29, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Giorgio Vittorio ScagliottiDavid Gandara
Jul 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Fred R HirschDavid R Gandara
Jul 16, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Chang-Qi ZhuUNKNOWN National Cancer Institute of Canada Clinical Trials Group Study BR.21
Aug 6, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·UNKNOWN NSCLC Meta-Analyses Collaborative Group
Oct 24, 2008·The New England Journal of Medicine·Christos S KarapetisJohn R Zalcberg
Dec 3, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gregory J RielyCharles M Rudin

❮ Previous
Next ❯

Citations

Apr 6, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lily ClaassensAndrew Bottomley
Apr 26, 2011·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Victoria J Muir, Sohita Dhillon
Mar 26, 2011·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Mark Murphy, Britta Stordal
Nov 3, 2010·Journal of Pediatric Surgery·Ryan J SummersLouis Rapkin
Sep 14, 2012·CA: a Cancer Journal for Clinicians·Joel B EpsteinEllie Maghami
Nov 26, 2010·The Mount Sinai Journal of Medicine, New York·Jaya SangodkarGoutham Narla
May 12, 2017·Journal of Cachexia, Sarcopenia and Muscle·Asta ByeMarit Jordhøy
Oct 14, 2014·The Clinical Respiratory Journal·Florent VinasChristos Chouaid

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Related Papers

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
John GoffinLung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-Based Care
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Fred R HirschWilbur A Franklin
© 2021 Meta ULC. All rights reserved